Determinants of immunodominance for CD4 T cells

Current Opinion in Immunology

Volumn 34, Issue , 2015, Pages 9-15

  Kim, AeRyon ^a   Sadegh Nasseri, Scheherazade ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CATHEPSIN; CHAPERONE; EPITOPE; B LYMPHOCYTE ANTIGEN; HLA ANTIGEN CLASS 2; INVARIANT CHAIN;

AMINO ACID SEQUENCE; ANTIGEN PRESENTATION; CD4+ T LYMPHOCYTE; CELL MEMBRANE; CELL VACUOLE; CELLULAR IMMUNITY; ENZYME DENATURATION; HELPER CELL; HUMAN; IMMUNODOMINANCE; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PH; REVIEW; T LYMPHOCYTE; ANIMAL; IMMUNOLOGY; METABOLISM;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; CATHEPSINS; CD4-POSITIVE T-LYMPHOCYTES; EPITOPES; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS;

EID: 84920683669     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2014.12.005     Document Type: Review

References (59)

1. Sercarz E.E., Lehmann P.V., Ametani A., Benichou G., Miller A., Moudgil K. Dominance and crypticity of T cell antigenic determinants. Annu Rev Immunol 1993, 11:729-766.
2. Hartman I.Z., Kim A., Cotter R.J., Walter K., Dalai S.K., Boronina T., Griffith W., Lanar D.E., Schwenk R., Krzych U., et al. A reductionist cell-free major histocompatibility complex class II antigen processing system identifies immunodominant epitopes. Nat Med 2010, 16:1333-1340.
3. Blum J.S., Wearsch P.A., Cresswell P. Pathways of antigen processing. Ann Rev Immunol 2013, 31:443-473.
4. Morris P., Shaman J., Attaya M., Amaya M., Goodman S., Bergman C., Monaco J.J., Mellins E. An essential role for HLA-DM in antigen presentation by class II major histocompatibility molecules. Nature 1994, 368:551-554.
5. Narayan K., Chou C.L., Kim A., Hartman I.Z., Dalai S., Khoruzhenko S., Sadegh-Nasseri S. HLA-DM targets the hydrogen bond between the histidine at position beta81 and peptide to dissociate HLA-DR-peptide complexes. Nat Immunol 2007, 8:92-100.
6. Surh C.D., Sprent J. Homeostasis of naive and memory T cells. Immunity 2008, 29:848-862.
7. Vezys V., Yates A., Casey K.A., Lanier G., Ahmed R., Antia R., Masopust D. Memory CD8 T-cell compartment grows in size with immunological experience. Nature 2009, 457:196-199.
8. Dai G., Steede N.K., Landry S.J. Allocation of helper T-cell epitope immunodominance according to three-dimensional structure in the human immunodeficiency virus type I envelope glycoprotein gp120. J Biol Chem 2001, 276:41913-41920.
9. Lee P., Matsueda G.R., Allen P.M. T cell recognition of fibrinogen. A determinant on the A alpha-chain does not require processing. J Immunol 1988, 140:1063-1068.
10. Thomas J.W., Danho W., Bullesbach E., Fohles J., Rosenthal A.S. Immune response gene control of determinant selection. III. Polypeptide fragments of insulin are differentially recognized by T but not by B cells in insulin immune guinea pigs. J Immunol 1981, 126:1095-1100.
11. Zamvil S.S., Mitchell D.J., Moore A.C., Kitamura K., Steinman L., Rothbard J.B. T-cell epitope of the autoantigen myelin basic protein that induces encephalomyelitis. Nature 1986, 324:258-260.
12. Ultee M.E., Margoliash E., Lipkowski A., Flouret G., Solinger A.M., Lebwohl D., Matis L.A., Chen C., Schwartz R.H. The T lymphocyte response to cytochrome C - II. Molecular characterization of a pigeon cytochrome c determinant recognized by proliferating T lymphocytes of the B10.A mouse. Mol Immunol 1980, 17:809-822.
13. Nepom G.T., Lippolis J.D., White F.M., Masewicz S., Marto J.A., Herman A., Luckey C.J., Falk B., Shabanowitz J., Hunt D.F., et al. Identification and modulation of a naturally processed T cell epitope from the diabetes-associated autoantigen human glutamic acid decarboxylase 65 (hGAD65). Proce Natl Acad Sci U S A 2001, 98:1763-1768.
14. Guillet J.G., Lai M.Z., Briner T.J., Smith J.A., Gefter M.L. Interaction of peptide antigens and class II major histocompatibility complex antigens. Nature 1986, 324:260-262.
15. Thomas D.W., Hsieh K.H., Schauster J.L., Mudd M.S., Wilner G.D. Nature of T lymphocyte recognition of macrophage-associated antigens. V. Contribution of individual peptide residues of human fibrinopeptide B to T lymphocyte responses. J Exp Med 1980, 152:620-632.
16. Solinger A.M., Ultee M.E., Margoliash E., Schwartz R.H. T-lymphocyte response to cytochrome C. I. Demonstration of a T-cell heteroclitic proliferative response and identification of a topographic antigenic determinant on pigeon cytochrome c whose immune recognition requires two complementing major histocompatibility complex-linked immune response genes. J Exp Med 1979, 150:830-848.
17. Maric M., Arunachalam B., Phan U.T., Dong C., Garrett W.S., Cannon K.S., Alfonso C., Karlsson L., Flavell R.A., Cresswell P. Defective antigen processing in GILT-free mice. Science 2001, 294:1361-1365.
18. Trombetta E.S., Mellman I. Cell biology of antigen processing in vitro and in vivo. Annu Rev Immunol 2005, 23:975-1028.
19. Kim A., Hartman I.Z., Poore B., Boronina T., Cole R.N., Song N., Ciudad M.T., Caspi R.R., Jaraquemada D., Sadegh-Nasseri S. Divergent paths for the selection of immunodominant epitopes from distinct antigenic sources. Nat Commun 2014, 5:5369.
20. van den Hoorn T., Paul P., Jongsma M.L., Neefjes J. Routes to manipulate MHC class II antigen presentation. Curr Opin Immunol 2011, 23:88-95.
21. Yin L., Calvo-Calle J.M., Dominguez-Amorocho O., Stern L.J. HLA-DM constrains epitope selection in the human CD4 T cell response to vaccinia virus by favoring the presentation of peptides with longer HLA-DM-mediated half-lives. J Immunol 2012, 189:3983-3994.
22. McCurley N., Mellman I. Monocyte-derived dendritic cells exhibit increased levels of lysosomal proteolysis as compared to other human dendritic cell populations. PLoS ONE 2010, 5:e11949.
23. Delamarre L., Pack M., Chang H., Mellman I., Trombetta E.S. Differential lysosomal proteolysis in antigen-presenting cells determines antigen fate. Science 2005, 307:1630-1634.
24. Trombetta E.S., Ebersold M., Garrett W., Pypaert M., Mellman I. Activation of lysosomal function during dendritic cell maturation. Science 2003, 299:1400-1403.
25. Manoury B. Proteases: essential actors in processing antigens and intracellular toll-like receptors. Front Immunol 2013, 4:299.
26. Hsing L.C., Rudensky A.Y. The lysosomal cysteine proteases in MHC class II antigen presentation. Immunol Rev 2005, 207:229-241.
27. Chapman H.A. Endosomal proteases in antigen presentation. Curr Opin Immunol 2006, 18:78-84.
28. Villadangos J.A., Ploegh H.L. Proteolysis in MHC class II antigen presentation: who's in charge?. Immunity 2000, 12:233-239.
29. Honey K., Rudensky A.Y. Lysosomal cysteine proteases regulate antigen presentation. Nat Rev Immunol 2003, 3:472-482.
30. Pluger E.B., Boes M., Alfonso C., Schroter C.J., Kalbacher H., Ploegh H.L., Driessen C. Specific role for cathepsin S in the generation of antigenic peptides in vivo. Eur J Immunol 2002, 32:467-476.
31. Riese R.J., Wolf P.R., Bromme D., Natkin L.R., Villadangos J.A., Ploegh H.L., Chapman H.A. Essential role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading. Immunity 1996, 4:357-366.
32. Nakagawa T.Y., Brissette W.H., Lira P.D., Griffiths R.J., Petrushova N., Stock J., McNeish J.D., Eastman S.E., Howard E.D., Clarke S.R., et al. Impaired invariant chain degradation and antigen presentation and diminished collagen-induced arthritis in cathepsin S null mice. Immunity 1999, 10:207-217.
33. Nakagawa T., Roth W., Wong P., Nelson A., Farr A., Deussing J., Villadangos J.A., Ploegh H., Peters C., Rudensky A.Y. Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus. Science 1998, 280:450-453.
34. Manoury B., Mazzeo D., Fugger L., Viner N., Ponsford M., Streeter H., Mazza G., Wraith D.C., Watts C. Destructive processing by asparagine endopeptidase limits presentation of a dominant T cell epitope in MBP. Nat Immunol 2002, 3:169-174.
35. Watts C., Moss C.X., Mazzeo D., West M.A., Matthews S.P., Li D.N., Manoury B. Creation versus destruction of T cell epitopes in the class II MHC pathway. Ann N Y Acad Sci 2003, 987:9-14.
36. Deussing J., Roth W., Saftig P., Peters C., Ploegh H.L., Villadangos J.A. Cathepsins B and D are dispensable for major histocompatibility complex class II-mediated antigen presentation. Proc Natl Acad Sci U S A 1998, 95:4516-4521.
37. Burster T., Reich M., Zaidi N., Voelter W., Boehm B.O., Kalbacher H. Cathepsin E regulates the presentation of tetanus toxin C-fragment in PMA activated primary human B cells. Biochem Biophys Res Commun 2008, 377:1299-1303.
38. Burster T., Macmillan H., Hou T., Boehm B.O., Mellins E.D. Cathepsin G: roles in antigen presentation and beyond. Mol Immunol 2010, 47:658-665.
39. Lazarski C.A., Chaves F.A., Jenks S.A., Wu S., Richards K.A., Weaver J.M., Sant A.J. The kinetic stability of MHC class II: peptide complexes is a key parameter that dictates immunodominance. Immunity 2005, 23:29-40.
40. Sloan V.S., Cameron P., Porter G., Gammon M., Amaya M., Mellins E., Zaller D.M. Mediation by HLA-DM of dissociation of peptides from HLA-DR. Nature 1995, 375:802-806.
41. Weber D.A., Evavold B.D., Jensen P.E. Enhanced dissociation of HLA-DR-bound peptides in the presence of HLA-DM. Science 1996, 274:618-620.
42. Kropshofer H., Vogt A.B., Moldenhauer G., Hammer J., Blum J.S., Hammerling G.J. Editing of the HLA-DR-peptide repertoire by HLA-DM. EMBO J 1996, 15:6144-6154.
43. Chou C.L., Sadegh-Nasseri S. HLA-DM recognizes the flexible conformation of major histocompatibility complex class II. J Exp Med 2000, 192:1697-1706.
44. Sadegh-Nasseri S., Chou C.L., Hartman I.Z., Kim A., Narayan K. How HLA-DM works: recognition of MHC II conformational heterogeneity. Front Biosci 2012, 4:1325-1332.
45. Pu Z., Lovitch S.B., Bikoff E.K., Unanue E.R. T cells distinguish MHC-peptide complexes formed in separate vesicles and edited by H2-DM. Immunity 2004, 20:467-476.
46. Pos W., Sethi D.K., Call M.J., Schulze M.S., Anders A.K., Pyrdol J., Wucherpfennig K.W. Crystal structure of the HLA-DM-HLA-DR1 complex defines mechanisms for rapid peptide selection. Cell 2012, 151:1557-1568.
47. Anders A.K., Call M.J., Schulze M.S., Fowler K.D., Schubert D.A., Seth N.P., Sundberg E.J., Wucherpfennig K.W. HLA-DM captures partially empty HLA-DR molecules for catalyzed removal of peptide. Nat Immunol 2011, 12:54-61.
48. Yin L., Trenh P., Guce A., Wieczorek M., Lange S., Sticht J., Jiang W., Bylsma M., Mellins E.D., Freund C., et al. Susceptibility to HLA-DM is determined by a dynamic conformation of major histocompatibility complex class II molecule bound with peptide. J Biol Chem 2014, 289:23449-23464.
49. Wolf P.R., Tourne S., Miyazaki T., Benoist C., Mathis D., Ploegh H.L. The phenotype of H-2M-deficient mice is dependent on the MHC class II molecules expressed. Eur J Immunol 1998, 28:2605-2618.
50. + T cell maturation in BALB/c mice. J Immunol 2001, 166:5087-5098.
51. Poluektov Y.O., Kim A., Sadegh-Nasseri S. HLA-DO and its role in MHC class II antigen presentation. Front Immunol 2013, 4:260.
52. Poluektov Y.O., Kim A., Hartman I.Z., Sadegh-Nasseri S. HLA-DO as the optimizer of epitope selection for MHC class II antigen presentation. PLOS ONE 2013, 8:e71228.
53. Denzin L.K., Cresswell P. Sibling rivalry: competition between MHC class II family members inhibits immunity. Nat Struct Mol Biol 2013, 20:7-10.
54. Guce A.I., Mortimer S.E., Yoon T., Painter C.A., Jiang W., Mellins E.D., Stern L.J. HLA-DO acts as a substrate mimic to inhibit HLA-DM by a competitive mechanism. Nat Struct Mol Biol 2013, 20:90-98.
55. Campos-Lima P.O., Levitsky V., Imreh M.P., Gavioli R., Masucci M.G. Epitope-dependent selection of highly restricted or diverse T cell receptor repertoires in response to persistent infection by Epstein-Barr virus. J Exp Med 1997, 186:83-89.
56. Perkins D.L., Wang Y.S., Fruman D., Seidman J.G., Rimm I.J. Immunodominance is altered in T cell receptor (beta-chain) transgenic mice without the generation of a hole in the repertoire. J Immunol 1991, 146:2960-2964.
57. Kedl R.M., Kappler J.W., Marrack P. Epitope dominance, competition and T cell affinity maturation. Curr Opin Immunol 2003, 15:120-127.
58. Lovitch S.B., Unanue E.R. Conformational isomers of a peptide-class II major histocompatibility complex. Immunol Rev 2005, 207:293-313.
59. Moon J.J., Chu H.H., Pepper M., McSorley S.J., Jameson S.C., Kedl R.M., Jenkins M.K. Naive CD4(+) T cell frequency varies for different epitopes and predicts repertoire diversity and response magnitude. Immunity 2007, 27:203-213.